Introduction: Final height in boys with delayed puberty is thought to be below target height. This conclusion, however, is based on studies that included patients with genetic short stature. We therefore studied final height in a group of 33 untreated boys with delayed puberty with a target height >–1.5 SDS. Methods: Standing height, sitting height, weight and arm span width were measured in each patient. Final height was predicted by the method of Greulich and Pyle using the tables of Bailey and Pinneau for retarded boys at their bone age (PAH1) and the tables of Bailey and Pinneau for average boys plus six months (PAH2). Results: Mean final height (175.8 ± 6.5 cm) was appropriate for the mean target height (174.7 ± 4.5 cm). The prediction method of Bailey and Pinneau overestimated the final height by 1.4 cm and the modified prediction method slightly underestimated the final height (–0.15 cm). Conclusion: Boys with untreated delayed puberty reach a final height appropriate for their target height. Final height was best predicted by the method of Bailey and Pinneau using the tables for average boys at their bone age plus six months.

Keywords:
Height prediction, Total pubertal height gain, Delayed puberty, Boys, Final height
1.
Albanese A, Stanhope R: Investigation of delayed puberty. Clin Endocrinol (Oxf) 1995;43:105–110.
2.
Stanhope R, Albanese A, Shalet S: Delayed puberty. BMJ 1992;305:790.
3.
Bierich JR: Constitutional delay of growth and adolescence. Baillieres Clin Endocrinol Metab 1992;6:573–588.
4.
Rosenfield RL: Clinical review 6: Diagnosis and management of delayed puberty. J Clin Endocrinol Metab 1990;70:559–562.
5.
Bramswig JH, Fasse M, Holthoff ML, von Lengerke HJ, von Petrykowski W, Schellong G: Adult height in boys and girls with untreated short stature and constitutional delay of growth and puberty: accuracy of five different methods of height prediction. J Pediatr 1990;117:886–891.
6.
Arrigo T, Cisternino M, Luca DF, Saggese G, Messina MF, Pasquino AM, De Sanctis V: Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty. J Pediatr Endocrinol Metab 1996;9:511–517.
7.
Crowne EC, Shalet SM, Wallace WH, Eminson DM, Price DA: Final height in boys with untreated constitutional delay in growth and puberty. Arch Dis Child 1990;65:1109–1112.
8.
Salerno M, De Filippo G, Di Maio S: [Definitive body height in constitutional retardation of growth and puberty]. Arch Pediatr 1996;3:866–869.
9.
LaFranchi S, Hanna CE, Mandel SH: Constitutional delay of growth: expected versus final adult height. Pediatrics 1991;87:82–87.
10.
Albanese A, Stanhope R: Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty. J Pediatr 1995;126:545–550.
11.
Sperlich M, Butenandt O, Schwarz HP: Final height and predicted height in boys with untreated constitutional growth delay. Eur J Pediatr 1995;154:627–632.
12.
Ferrandez LA, Mayayo E, Valle A, Soria J, Labarta JI: Constitutional delay in growth and puberty: a comparison of final height achieved between treated and untreated children. J Pediatr Endocrinol Metab 1996;9(suppl 3):345–357.
13.
Du Caju MV, Op de Beeck L, Sys SU, Hagendorens MM, Rooman RP: Progressive deceleration in growth as an early sign of delayed puberty in boys. Horm Res 2000;54:126–130.
14.
Albanese A, Stanhope R: Does constitutional delayed puberty cause segmental disproportion and short stature? Eur J Pediatr 1993;152:293–296.
15.
Maes M, Vandeweghe M, Du CM, Ernould C, Bourguignon JP, Massa G: A valuable improvement of adult height prediction methods in short normal children. Horm Res 1997;48:184–190.
16.
Karlberg J, Lawrence C, Albertsson-Wikland K: Prediction of final height in short, normal and tall children. Acta Paediatr Suppl 1994;406:3–9.
17.
Preece MA: Prediction of adult height: methods and problems. Acta Paediatr Scand Suppl 1988;347:4–11.
18.
Lenko HL: Prediction of adult height with various methods in Finnish children. Acta Paediatr Scand 1979;68:85–92.
19.
Rochiccioli P, Tock Mine YY, Enjaume C, Dutau G, Sablayrolles B: [The delay of bone maturation is a favorable element in the prognosis of final height]. Arch Fr Pediatr 1985;42:273–276.
20.
Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, ed 2. Stanford, Stanford University Press, 1959.
21.
Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA: Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995;73:17–24.
22.
Hintz RL: Final height prediction in constitutional growth delay. J Pediatr Endocrinol Metab 2001;14(suppl 6):1535–1540.
23.
Roche AF, Wainer H, Thissen D: The RWT method for the prediction of adult stature. Pediatrics 1975;56:1027–1033.
24.
Tanner JM, Landt KW, Cameron N, Carter BS, Patel J: Prediction of adult height from height and bone age in childhood. A new system of equations (TW Mark II) based on a sample including very tall and very short children. Arch Dis Child 1983;58:767–776.
25.
Zadik Z, Segal N, Limony Y: Final height prediction models for pubertal boys. Acta Paediatr Suppl 1996;417:53–56.
26.
Gerver WJM, de Bruin R: Paediatric Morphometrics. Maastricht, University Press, 2001.
27.
Tanner JM, Whitehouse RH, Marubini E, Resele LF: The adolescent growth spurt of boys and girls of the Harpenden growth study. Ann Hum Biol 1976;3:109–126.
28.
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.
29.
He Q, Karlberg J: BMI in childhood and its association with height gain, timing of puberty, and final height. Pediatr Res 2001;49:244–251.
30.
Gill MS, Toogood AA, O’Neill PA, et al: Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects. Clin Endocrinol (Oxf) 1997;47:161–167.
31.
Clayton PE, Gill MS, Hall CM, Tillmann V, Whatmore AJ, Price DA: Serum leptin through childhood and adolescence. Clin Endocrinol (Oxf) 1997;46:727–733.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.